Chuan Zheng

1.8k total citations
64 papers, 1.3k citations indexed

About

Chuan Zheng is a scholar working on Molecular Biology, Complementary and alternative medicine and Immunology. According to data from OpenAlex, Chuan Zheng has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 8 papers in Complementary and alternative medicine and 8 papers in Immunology. Recurrent topics in Chuan Zheng's work include Nanoplatforms for cancer theranostics (5 papers), Natural product bioactivities and synthesis (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Chuan Zheng is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Natural product bioactivities and synthesis (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Chuan Zheng collaborates with scholars based in China, Hong Kong and Macao. Chuan Zheng's co-authors include Fengming You, Jie Zhu, Hong Yang, Chunhui Wu, Xiang Qin, Jinming Zhang, Chen Zhang, Shun Li, Yiyao Liu and Xuemei Wan and has published in prestigious journals such as Biomaterials, Bioresource Technology and Scientific Reports.

In The Last Decade

Chuan Zheng

59 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuan Zheng China 23 511 218 156 126 114 64 1.3k
Parichehreh Yaghmaei Iran 26 841 1.6× 299 1.4× 206 1.3× 128 1.0× 79 0.7× 174 2.2k
Asieh Hosseini Iran 23 469 0.9× 310 1.4× 170 1.1× 141 1.1× 51 0.4× 61 2.0k
Chuwen Li China 28 777 1.5× 145 0.7× 83 0.5× 183 1.5× 100 0.9× 79 1.9k
Yue Dai China 24 611 1.2× 361 1.7× 213 1.4× 70 0.6× 114 1.0× 65 1.7k
Thiyagarajan Ramesh Saudi Arabia 23 567 1.1× 178 0.8× 109 0.7× 181 1.4× 43 0.4× 92 1.8k
Xiaomei Wu China 26 694 1.4× 196 0.9× 180 1.2× 81 0.6× 55 0.5× 120 2.0k
Amna Parveen South Korea 23 476 0.9× 125 0.6× 172 1.1× 73 0.6× 48 0.4× 45 1.4k
Lei Sheng China 31 665 1.3× 251 1.2× 118 0.8× 63 0.5× 61 0.5× 86 2.6k
Yang Niu China 24 464 0.9× 170 0.8× 72 0.5× 154 1.2× 59 0.5× 56 1.3k
Pei‐Wen Cheng Taiwan 20 673 1.3× 122 0.6× 99 0.6× 78 0.6× 71 0.6× 73 2.2k

Countries citing papers authored by Chuan Zheng

Since Specialization
Citations

This map shows the geographic impact of Chuan Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Zheng more than expected).

Fields of papers citing papers by Chuan Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Zheng. The network helps show where Chuan Zheng may publish in the future.

Co-authorship network of co-authors of Chuan Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Zheng. A scholar is included among the top collaborators of Chuan Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Zheng. Chuan Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Yao, Huan, Yuanyuan Luo, Weiwei Liu, et al.. (2025). Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction. Acta Pharmaceutica Sinica B. 15(8). 4030–4046. 3 indexed citations
5.
Ganesan, Kumar, Cong Xu, Bing Du, et al.. (2024). Isoliquiritigenin: A natural compound with a promising role in inhibiting breast cancer lung metastasis. Journal of Traditional and Complementary Medicine. 15(7). 702–713. 2 indexed citations
6.
Tang, Zhentao, et al.. (2024). Biochar derived from traditional Chinese medicine residues: An efficient adsorbent for heavy metal Pb(II). Arabian Journal of Chemistry. 17(3). 105606–105606. 28 indexed citations
7.
Tang, Zhentao, et al.. (2024). Novel chitosan-modified biochar prepared from a Chinese herb residue for multiple heavy metals removal: Characterization, performance and mechanism. Bioresource Technology. 402. 130830–130830. 24 indexed citations
8.
Ganesan, Kumar, Fei Gao, Chuan Zheng, et al.. (2024). Isoliquiritigenin-infused electrospun nanofiber inhibits breast cancer proliferation and invasion through downregulation of PI3K/Akt/mTOR and MMP2/9 pathways. Journal of Drug Delivery Science and Technology. 96. 105609–105609. 5 indexed citations
9.
Song, Ting, Geng Yang, Hanxi Zhang, et al.. (2023). Enhanced ferroptosis therapy with a “nano-destructor” by disrupting intracellular redox and iron homeostasis. Nano Today. 51. 101896–101896. 26 indexed citations
10.
Yao, Huan, Qian Xie, Yuanyuan Gong, et al.. (2022). Pretreatment with Panaxatriol Saponin Attenuates Mitochondrial Apoptosis and Oxidative Stress to Facilitate Treatment of Myocardial Ischemia‐Reperfusion Injury via the Regulation of Keap1/Nrf2 Activity. Oxidative Medicine and Cellular Longevity. 2022(1). 9626703–9626703. 48 indexed citations
11.
Yao, Huan, Yuanyuan Gong, Xueping Li, et al.. (2022). Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation. Free Radical Biology and Medicine. 190. 264–275. 54 indexed citations
12.
Wang, Lun, Yan Jiang, Fu Li, et al.. (2021). Steroidal alkaloids from the bulbs of Fritillaria pallidiflora Schrenk and their anti-inflammatory activity. Bioorganic Chemistry. 112. 104845–104845. 17 indexed citations
13.
Li, Ping, Yu Chen, Yueting Peng, et al.. (2021). Notch‐1 signaling promotes reattachment of suspended cancer cells by cdc42‐dependent microtentacles formation. Cancer Science. 112(12). 4894–4908. 6 indexed citations
14.
Qin, Xiang, Yuehui Zhang, Kang Chen, et al.. (2021). Shear stress triggered circular dorsal ruffles formation to facilitate cancer cell migration. Archives of Biochemistry and Biophysics. 709. 108967–108967. 9 indexed citations
15.
Feng, Yi, Xiaoxue Xie, Hanxi Zhang, et al.. (2021). Multistage-responsive nanovehicle to improve tumor penetration for dual-modality imaging-guided photodynamic-immunotherapy. Biomaterials. 275. 120990–120990. 51 indexed citations
16.
Huang, Wei, et al.. (2020). Effectiveness and safety of traditional Chinese medicine Shaoyao Gancao Tang for the treatment of restless leg syndrome. Medicine. 99(40). e22401–e22401. 3 indexed citations
17.
Xie, Xiaoxue, Yu Chen, Zhongyuan Chen, et al.. (2019). Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging. ACS Applied Materials & Interfaces. 11(47). 43865–43878. 33 indexed citations
18.
Shen, Xue, Tingting Li, Zhongyuan Chen, et al.. (2019). NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform. Molecular Pharmaceutics. 16(3). 1367–1384. 41 indexed citations
19.
Jiang, Yifang, Fengming You, Jie Zhu, et al.. (2019). Cryptotanshinone Ameliorates Radiation-Induced Lung Injury in Rats. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 21 indexed citations
20.
Rao, Shuquan, Yao Yao, Chuan Zheng, et al.. (2016). Common variants in CACNA1C and MDD susceptibility: A comprehensive meta‐analysis. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 171(6). 896–903. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parichehreh Yaghmaei Breakdown of academic impact, for papers by Asieh Hosseini Breakdown of academic impact, for papers by Chuwen Li Breakdown of academic impact, for papers by Yue Dai Breakdown of academic impact, for papers by Thiyagarajan Ramesh Breakdown of academic impact, for papers by Xiaomei Wu Breakdown of academic impact, for papers by Amna Parveen Breakdown of academic impact, for papers by Lei Sheng Breakdown of academic impact, for papers by Yang Niu Breakdown of academic impact, for papers by Pei‐Wen Cheng
Rankless by CCL
2026